64 related articles for article (PubMed ID: 1535458)
1. Clinical impact of adoptive therapy with purified CD8 cells in HIV infection.
Klimas NG
Semin Hematol; 1992 Apr; 29(2 Suppl 1):40-3; discussion 43-4. PubMed ID: 1535458
[No Abstract] [Full Text] [Related]
2. Adoptive therapy with purified CD8 cells in HIV infection.
Herberman RB
Semin Hematol; 1992 Apr; 29(2 Suppl 1):35-40. PubMed ID: 1535457
[No Abstract] [Full Text] [Related]
3. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
Feuchtinger T; Lang P; Hamprecht K; Schumm M; Greil J; Jahn G; Niethammer D; Einsele H
Exp Hematol; 2004 Mar; 32(3):282-9. PubMed ID: 15003314
[TBL] [Abstract][Full Text] [Related]
4. T cells take aim at cancer.
Pardoll D
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15840-2. PubMed ID: 12461164
[No Abstract] [Full Text] [Related]
5. Interleukin-2 as therapy for HIV disease.
Landonio G; Baiocchi C; Ferrari M
N Engl J Med; 1995 Jul; 333(3):192-3. PubMed ID: 7791831
[No Abstract] [Full Text] [Related]
6. Regulatory T cells and transplantation tolerance.
Jiang S; Lechler RI; He XS; Huang JF
Hum Immunol; 2006 Oct; 67(10):765-76. PubMed ID: 17055353
[TBL] [Abstract][Full Text] [Related]
7. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
[TBL] [Abstract][Full Text] [Related]
8. FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection.
Ndhlovu LC; Loo CP; Spotts G; Nixon DF; Hecht FM
J Leukoc Biol; 2008 Feb; 83(2):254-62. PubMed ID: 17982112
[TBL] [Abstract][Full Text] [Related]
9. Suppressor function of lymphocytes activated in in vitro co-culture against autologous tumor cells and expanded in interleukin-2.
Okino T; Chakraborty NG; Ergin MT; Mukherji B
In Vivo; 1991; 5(6):631-5. PubMed ID: 1687355
[TBL] [Abstract][Full Text] [Related]
10. Immunology. An antibody paradox, resolved.
Prlic M; Bevan MJ
Science; 2006 Mar; 311(5769):1875-6. PubMed ID: 16574856
[No Abstract] [Full Text] [Related]
11. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
[TBL] [Abstract][Full Text] [Related]
12. Cellular basis of immunologic tolerance following total bowel transplantation in rats. II. Dominant role of suppressor T cells in adoptive transfer of acquired tolerance to vascularized allografts.
Masaki Y; Oohara T; Shinomiya T; Kimura H
Transplant Proc; 1995 Apr; 27(2):1589-92. PubMed ID: 7536972
[No Abstract] [Full Text] [Related]
13. Recovery of T-lymphocytes for adoptive immunotherapy by lymphapheresis of HIV-infected patients without alterations of virological, immunological or clinical parameters.
van Lunzen J; Schmitz J; Dengler K; Schmidt L; Schmitz H; Dietrich M
Br J Haematol; 1994 Sep; 88(1):46-51. PubMed ID: 7803255
[TBL] [Abstract][Full Text] [Related]
14. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
Smith PM; Wolcott RM; Chervenak R; Jennings SR
Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of the CD8 lymphocytes in healthy and HIV 1 infected subjects.
Arras M; Contu L
Allergol Immunopathol (Madr); 1991; 19(2):79-84. PubMed ID: 1722958
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of rat CD4(+)CD25(+) T cells and their ability to prevent not only diabetes but also insulitis in an adoptive transfer model in BB rats.
Holm TL; Lundsgaard D; Markholst H
Scand J Immunol; 2006 Jul; 64(1):17-29. PubMed ID: 16784487
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic efficacy of murine anti-tumor T cells: freshly isolated T cells are more therapeutic than T cells expanded in vitro.
Evans R; Kamdar SJ; Duffy TM; Krupke DM; Fuller JA; Dudley ME
Anticancer Res; 1995; 15(2):441-7. PubMed ID: 7763019
[TBL] [Abstract][Full Text] [Related]
19. Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy?
Mastroianni CM; d'Ettorre G; Forcina G; Vullo V
Trends Immunol; 2004 Mar; 25(3):121-5. PubMed ID: 15036038
[No Abstract] [Full Text] [Related]
20. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
